Member LoginDividend CushionValue Trap
|
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for
any changes.
Latest
Valuentum Commentary
May 13, 2016
Teva Bounces After Strong First Quarter
Image Source: Teva. Shares of Best Ideas Newsletter portfolio holding Teva Pharmaceuticals have experienced volatility in recent trading periods as the company continues to work towards finalizing its acquisition of Allergan’s generic drug portfolio and as market participants assess first quarter results. Apr 5, 2016
Treasury Erects Iron Tax Curtain
Image Description/Source: Berlin Wall, 1963; Roger. “If history is any guide, it would seem that tax lawmakers may want to think about the current political agenda’s similarities with respect to that of a “new” Berlin Wall--not one built of barbed wire but of prohibitive, restrictive tax laws--and whether such measures make sense in light of the events of the late 1980s.” – Valuentum Securities Feb 21, 2016
Growing Cautious on Teva Pharma
Best Ideas Newsletter portfolio holding Teva Pharmaceuticals reported a disappointing fourth quarter. Nov 23, 2015
Discuss: Taxes and the Future of American Business
Let's talk about whether tax inversions are a core part of the freedom that is innate to the American character. Nov 5, 2015
Catching Up With Some of Our Best Ideas
Let’s take a look at the recent performance of a few companies within the Best Ideas Newsletter portfolio. Aug 13, 2015
Big Pharma Earnings Continued…
Amgen, AstraZeneca, Merck, and Pfizer... Jul 28, 2015
Best Ideas Newsletter Holding Teva Surges!
Have you been paying attention to the best ideas? Jan 5, 2015
4 Opportunistic Stocks To Consider Buying in 2015
The Valuentum Buying Index has registered a high rating in the past on these four investment ideas. 2015 may mark strong gains for these gems. Jul 30, 2014
Big Pharma Round Up
Let’s take a look at recent quarterly results from Big Pharma. Jun 22, 2014
Valuentum Economic Castle™ Rating Update
Members should expect the initial Economic Castle™ ratings. Latest News and Media The High Yield Dividend Newsletter, Best Ideas
Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on
this website are for information purposes only and should not be considered a solicitation to buy or sell any
security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s
accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or
omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts
no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a
registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees,
and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.
|
